Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Frenkel

Showing results (321-330 of 383) with videos related to

Pageof 39
Sort By:
The Journal of Clinical Investigation|June 4, 2024
Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiationJaimy Joy, Ana Gervassi, Lennie Chen, et al.
AIDS (London, England)|April 5, 2019
Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan womenRoss S Milne, Rachel A Silverman, Ingrid A Beck, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have sex with men in Seattle/King County, WA, 2005-2007Susan E Buskin, Giovanina M Ellis, Gregory G Pepper, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 9, 2021
Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical TrialLisa M Frenkel, R Leavitt Morrison, Trevon L Fuller, et al.
AIDS (London, England)|October 28, 2022
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapyRoss S Milne, Ingrid A Beck, Molly Levine, et al.
The Journal of Infectious Diseases|October 18, 2017
Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug ResistanceHoracio A Duarte, Nuttada Panpradist, Ingrid A Beck, et al.
The Journal of Infectious Diseases|December 15, 2010
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected personsJared M Baeten, Jairam Lingappa, Ingrid Beck, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2026
Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations with Risk of Postnatal HIV Transmission during Breastfeeding Among Women with and without ARV ExposureMaxensia Owor, Kristin Baltrusaitis, Patricia DeMarrais, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Multi-species genome-wide CRISPR screens identify conserved suppressors of cold-induced cell deathBreanna Lam, Kathrin M Kajderowicz, Heather R Keys, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2003
Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survivalArlene D Bardeguez, David E Shapiro, Lynne M Mofenson, et al.
Pageof 39

Showing results (321-330 of 383) with videos related to

Sort By:
Pageof 39
The Journal of Clinical Investigation|June 4, 2024
Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiationJaimy Joy, Ana Gervassi, Lennie Chen, et al.
AIDS (London, England)|April 5, 2019
Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan womenRoss S Milne, Rachel A Silverman, Ingrid A Beck, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have sex with men in Seattle/King County, WA, 2005-2007Susan E Buskin, Giovanina M Ellis, Gregory G Pepper, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 9, 2021
Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical TrialLisa M Frenkel, R Leavitt Morrison, Trevon L Fuller, et al.
AIDS (London, England)|October 28, 2022
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapyRoss S Milne, Ingrid A Beck, Molly Levine, et al.
The Journal of Infectious Diseases|October 18, 2017
Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug ResistanceHoracio A Duarte, Nuttada Panpradist, Ingrid A Beck, et al.
The Journal of Infectious Diseases|December 15, 2010
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected personsJared M Baeten, Jairam Lingappa, Ingrid Beck, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2026
Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations with Risk of Postnatal HIV Transmission during Breastfeeding Among Women with and without ARV ExposureMaxensia Owor, Kristin Baltrusaitis, Patricia DeMarrais, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Multi-species genome-wide CRISPR screens identify conserved suppressors of cold-induced cell deathBreanna Lam, Kathrin M Kajderowicz, Heather R Keys, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2003
Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survivalArlene D Bardeguez, David E Shapiro, Lynne M Mofenson, et al.
Pageof 39